Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients

Research output: Contribution to journalReviewResearchpeer-review

  1. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Measured and genetically predicted plasma YKL-40 levels and melanoma mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Combining conventional therapy with immunotherapy: A risky business?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Trends of ankyloglossia and lingual frenotomy in hospital settings among children in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. High nodal FDG uptake increases risk of distant metastasis in patients with oropharyngeal squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Improved Survival of Children, Adolescents, and Young Adults With Head and Neck Soft Tissue Sarcomas in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. European Position Paper on Rhinosinusitis and Nasal Polyps 2020

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) is rapidly increasing in incidence and has a favourable prognosis compared with HPV-negative disease. Current combined therapies include significant risks of morbidity for the growing group of survivors. This systematic review and meta-analysis investigates how treatment affects quality of life (QoL) in survivors of oropharyngeal cancer. PubMed, EMBASE and the Cochrane Library were systematically searched for all studies reporting patient-assessed QoL at least 1 year after treatment for OPC. In a meta-analysis, weighted average QoL scores from the four most commonly utilised QoL instruments were compared with baseline and reference group scores using the concept of minimal clinically important difference. The meta-analysis included data from 1366 patients from 25 studies and 12 countries. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30) was answered by 704 patients, 644 patients answered the EORTC QLQ Head and Neck-35 (H&N-35), 474 patients answered the University of Washington Quality of Life Questionnaire, and 381 patients answered the M. D. Anderson Dysphagia Inventory. Moderate to large clinically important deteriorations in QoL were found in the domains dry mouth and sticky saliva for the EORTC QLQ-H&N35, saliva, chewing, swallowing, speech, taste, appearance and shoulder for the University of Washington Quality of Life Questionnaire, and the global, physical and emotional subscales for the M. D. Anderson Dysphagia Inventory. In conclusion, survivors of OPC face clinically important deteriorations in QoL that most markedly centre on xerostomia, dysphagia and chewing. These ailments indicate a potential for improvement in patient management.

Original languageEnglish
JournalEuropean journal of cancer (Oxford, England : 1990)
Volume78
Pages (from-to)91-102
Number of pages12
ISSN0959-8049
DOIs
Publication statusPublished - Jun 2017

    Research areas

  • Adult, Aged, Combined Modality Therapy, Deglutition Disorders, Female, Humans, Male, Mastication, Middle Aged, Oropharyngeal Neoplasms, Papillomavirus Infections, Psychiatric Status Rating Scales, Quality of Life, Surveys and Questionnaires, Survivors, Xerostomia, Journal Article, Meta-Analysis, Review

ID: 52148143